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The selectivity of the adaptive immune response is based on the enormous diversity of 
T and B cell antigen-specific receptors. The immune repertoire, the collection of T and B 
cells with functional diversity in the circulatory system at any given time, is dynamic and 
reflects the essence of immune selectivity. In this article, we review the recent advances 
in immune repertoire study of infectious diseases, which were achieved by traditional 
techniques and high-throughput sequencing (HTS) techniques. HTS techniques enable 
the determination of complementary regions of lymphocyte receptors with unprece-
dented efficiency and scale. This progress in methodology enhances the understanding 
of immunologic changes during pathogen challenge and also provides a basis for further 
development of novel diagnostic markers, immunotherapies, and vaccines.
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iNTRODUCTiON
The adaptive immune system is composed of B and T cells that form a highly selective guard against 
evolving pathogens. The foundation of the adaptive immune response is based on the enormous 
diversity of T and B cell antigen receptors that can recognize epitopes from a near infinite number 
of different internal and external antigens. This profound diversity of T (TCRs) and B cell receptors 
(BCRs) is generated by V–D–J gene recombination of the TCR/BCR locus and subsequent somatic 
hypermutation and class-switching recombination of B cells after antigen stimulation. Thus, study of 
the immune repertoire, portrayed as the antigen-specific information within lymphocytes, has been 
a key to understanding the response of adaptive immunity during infection.
Despite extensive efforts using traditional techniques, analysis of the immune repertoire with high 
resolution has remained difficult. Several sequencing strategies, for example, Sanger sequencing, 
have been implemented to determine cDNA segments encoding variable regions of immunoglobulin 
(or TCRs) (1, 2). However, these low-throughput techniques lack the power to provide a broad 
picture of the full immune repertoire. During the past two decades, however, technical advances 
in high-throughput sequencing (HTS), also known as next-generation sequencing (NGS), along 
with evolving bioinformatic and statistical tools, have provided a new approach capable of analyz-
ing the immune repertoire at the single sequence level. These methods create an unprecedentedly 
high-resolution picture of the immune repertoire and also provide massive data that cover each 
lymphocyte from the sample, in theory, dispensing with limitation of sequencing quantity (3).
Considering the extremely important role of the adaptive immune system in defending against 
infectious agents, HTS has great potential to aid in the discovery novel infectious agents and also 
FiGURe 1 | Process of generating a diverse B cell repertoire. The structure of each heavy chain (left) originates from rearrangement of Variable (V), Diversity 
(D), and Joining (J) gene segments. Recombination occurs first between D and J segment, and then V segment and D-J segment. Along with the selection of gene 
segments, insertion and deletion of nucleotides at the junctions between segments provides initial diversity for the primary BCR repertoire. In comparison, the light 
chain (right) is formed only by two segments (V and J), which makes the light chain to be less diverse. After encountering cognate antigen, somatic hypermutation 
introduces point mutations to frame region and complementary determining region of BCRs. This process further diversifies the repertoire and generates BCRs with 
higher affinity.
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offers new approaches for antibody or vaccine development. 
In this review, we introduce the implementation of HTS to 
the study of the immune repertoire and review the associated 
bioinformatic tools required for data processing and analysis. 
We then focus on the success of this technology in facilitating 
the exploration of infection-related immune repertoires for 
clinical diagnosis, treatment, and prevention.
GeNeRATiON OF A DiveRSe iMMUNe 
RePeRTOiRe
Amazing diversity makes the immune system the most effective 
system to fight against a broad scope of disease causing patho-
gens. This repertoire is generated by a complex series of genetic 
events (4). For T cells, the variable region of each TCR chain 
consists of three complementary determining regions (CDRs) 
and four frame regions (FRs). CDRs are the variable portion of 
the receptor and determine the antigen specificity. While CDR1 
and CDR2 are formed by variable (V) gene, CDR3 is generated 
by random selection and recombination of variable (V), diversity 
(D), and joining (J) gene segments in the heavy chain (V and 
J region gene segments in light chain) (5, 6) (Figure  1). Thus, 
CDR3 is the most diverse component of a receptor, which binds 
MHC molecules and (or) antigens. Construction of the TCR with 
an alpha chain and a beta chain is also a process that contributes 
to receptor diversity.
The formation and revision of the T and B cell lymphocyte 
receptor repertoire is a highly dynamic process. The number of 
each lymphocyte clone changes dramatically and depends on cell 
specificity and the history of antigen exposure. When encounter-
ing exogenous antigens, T cells that express receptors capable 
of binding to a specifically compatible peptide–MHC (pMHC) 
complex will expand, resulting in a massive population of anti-
gen-specific T cells that initiate the adaptive immune response 
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(7–11). This antigen-driven proliferation process of T cells is 
distinct between CD4+ and CD8+ T cells after initial antigenic 
stimulus. Although these two types of T cells show comparable 
protein expression, proliferation rate, and transcriptome features 
after 2 days of non-infective stimulation, subsequent division of 
T cells differently depends on continuous existence of self-pMHC 
complexes. CD4+ T cells proliferate in a limited pattern, and 
its subsequent response requires persistent stimulation from 
antigen-presenting cells. CD8+ T cell is “programed” to extensive 
expansion after short stimulation even when transferred into 
antigen-free hosts (12).
The post-antigen stimulation response of B cells is more com-
plicated because it is accompanied by somatic hypermutation and 
class-switch recombination that offer additional diversification of 
the B cell repertoire (6). Somatic hypermutation is the process of 
introducing point mutations at CDR1, CDR2, CDR3, and FR3 to 
produce B cells of higher affinity to target antigens. These higher 
affinity clones are then selected and expanded, which is called 
affinity maturation. Additionally, in class-switch recombination, 
the gene loci encoding the C region of BCRs are excised and 
replaced by a series of new constant gene segments, resulting in 
functional differences of IgG, IgE, or IgA that participate in differ-
ent immune mechanisms during pathogen elimination.
HiGH-THROUGHPUT  
SeQUeNCiNG – A New STRATeGY 
FOR iMMUNe RePeRTOiRe ANALYSiS
Traditional Strategies for Studying the 
immune Repertoire
Prior to HTS, many strategies were developed to explore post-
infection immune repertoires (13). Immunoscope spectratyping 
has been used to investigate TCR/BCR repertoires since the 1990s 
(5, 14). In this technique, using one (for B cell) or more (for T 
cell) V or J gene specific primer pairs, the length of CDR3 can be 
determined (15). CDR3 length in healthy population shows a bell-
shaped pattern, indicating a polyclonal repertoire. However, the 
unusual peaks in infected patients imply a perturbed oligoclonal 
repertoire with clonal expansion. As such, CDR3 spectratyping 
provides robust information on the complexity and stability of 
circulating T/B cell repertoires and insights into the immune 
repertoire after infection (16–20). Even if it is relatively easy and 
cheap, the nucleotide sequences of CDR3 remain obscure, and 
the extent of heterogeneity within a particular CDR3 length can-
not be assessed.
Detailed nucleotide sequences of gene segments encoding the 
variable region can be determined by traditional DNA sequencing 
techniques such as Sanger sequencing (21, 22). Flow cytometry 
and CDR3 spectratyping help to isolate T/B cells of interest, 
which complements weaknesses of Sanger sequencing in quantity 
limitation. Single-cell sequencing is able to identify sequences 
of several B cells that produce monoclonal antibodies specific 
to certain virus, which contributes greatly to analyzing genetic 
features of the antibodies in the process of antibody discovery 
(2, 22–24). After collecting peripheral blood samples, the B cells 
or memory B cells are isolated and immortalized to produce 
antibodies. According to the HAI titers and neutralizing titers 
determined by ELISA, the virus-specific B cells can be identified, 
which helps to narrow B cell candidates for sequencing. These 
functional test-based antibody discovery strategies are successful 
but laborious. Despite this, these strategies are well designed for 
targeted antibody searching; however, it is insufficient for creat-
ing a high-resolution picture of the human immune repertoire.
High-Throughput Sequencing 
of Lymphocyte Repertoires
High-throughput sequencing has recently become a novel and 
powerful tool to investigate the immune repertoire. The depth 
and comprehensiveness of high-throughput immune repertoire 
sequencing are greater than ever, and the enormous sequencing 
data of disease-specific TCR/BCR clones provide great potential 
for the revealing dynamic changes in clonality during infectious 
states.
Establishing a lymphocyte repertoire database starts from 
sample collection from carefully selected populations and 
isolation of interested T cell or B cell subgroups. Due to the 
well-acknowledged heterogeneity of TCRs and BCRs between 
individuals, longitudinal studies tracking dynamic alterations in 
certain population help to reduce difficulties in data interpretation 
at unraveling the infection course. Classification of subgroups of 
T cell and B cells, e.g., naive and memory T/B cells, CD4+, and 
CD8+ T cells, is necessary if distinct behavior of these subgroups 
is considered in detail.
The methodology of library preparation and amplification need 
careful design since it affects accuracy of the ultimate sequencing 
data. Due to the difference of V and J gene segments, a common 
primer does not apply to sequencing of CDR3. Multiplex PCR is 
capable to amplify multiple loci simultaneously and, however, is 
likely to introduce bias. It is because of non-specific amplifica-
tion, primer-dimer formation, and uneven reaction conditions. 
More precise and quantitative multiplex PCR may be achieved 
through primer concentration adjustment and bias filtering using 
amplification bias among the templates as controls (23). Another 
alternative PCR method is 5′RACE PCR, which provides a less 
biased PCR library using primers that bind downstream of the 
variable domain (24).
Sequencing techniques are evolving continuously to be deeper 
and more precise, and there are three prevalent HTS platforms 
available today. The comparison of mechanisms, sequencing 
depth, and other critical features of each platform is shown 
in Table  1. The Illumina and Roche 454 platforms have been 
most commonly used during immune repertoire analysis. The 
outputs of each platform must be analyzed with caution because 
of notable platform-specific sequencing error (25–28). Insertions 
and deletions of nucleotides, resulting from imperfect interpreta-
tion of homopolymeric stretches, are considerable for the Roche 
454 platform (29), while substitution errors are predominant in 
Illumina platform (30, 31). The overall error rate of Illumina 
platform is lowest while that of Ion Torrent is highest among 
the three (32). In an attempt to correct sequencing errors, three 
algorithms are most commonly used including k-mer spectrum, 
multiple sequence alignment, and suffix tree (26). Based on 
TABLe 1 | High-throughput sequencing platforms used for Lymphocyte Repertoire Study.
HTS platform Mechanism Read  
depth
Read  
length
Typical 
throughput
Covered 
region
Application Accuracy
Roche 454 GS FLX 
Titanium XLR70
Pyro-sequencing ~1 million Up to 600 bp 450 Mb FR1-C region BCR (long read), TCR 
(long read)
Consensus accuracy 
99.995%
Illumina HiSeq Dye terminator 
sequencing
~2 billion 2 × 250 bp 500–1000 Gb FR3-C region TCR (CDR3), BCR (long 
read), TCR (long read)
>80% bases above Q30
Illumina MiSeq Dye terminator 
sequencing
~25 million 2 × 150 bp 13.2–15 Gb FR1-C region TCR (CDR3) >80% bases higher than 
Q30 at 2 × 150 bp
2 × 300 bp >75% bases higher than 
Q30 at 2 × 250 bp
Ion Torrent/Life 
Technologies
Semiconductor 
sequencing
~1 billion Up to 200 bp 30 Mb–2 Gb FR3-C region TCR >97% bases
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these algorithms, bioinformatic tools are designed for different 
platforms, for example, BFC (33), HiTEC (34), Lighter (35), 
Reptile (36), and ECHO (37) are for Illumina platforms, and 
PyroNoise (38), DeNoiser (39), and HECTOR (40) are for 454 
platforms. Their main approaches, correction functions, and 
qualities are compared in Ref. (27).
PCR and sequencing errors inevitably result in overestimate 
of repertoire diversity. The common statistical strategy for both 
PCR and sequencing error removal is eliminating low abun-
dance and low-quality sequences (with low Phred score), but it 
leads to a great loss of sequencing information. To rescue these 
sequences, low-quality CDR3 sequences with no more than three 
low-quality nucleotides can be mapped to “core clonotypes” 
derived from high-quality sequences with allowed mismatches at 
low-quality position. Then, the low-abundance core clonotypes 
are merged with the high-abundance core clonotypes with less 
than three allowed mismatches at V (≤2 mismatches), D (≤1 
mismatches), and J (≤2 mismatches) gene segments to correct 
PCR errors. This integrated algorithm based on sequence quality 
abundance could efficiently correct artificial errors and avoid 
information loss, thus providing more reliable estimation of rep-
ertoire diversity (28). Unique molecular identifiers that label each 
starting molecule help to reduce both PCR and sequencing errors 
(24, 41). Combined with this experimental strategy, molecular 
identifier groups-based error correction (MIGEC) corrects PCR 
and sequencing errors more efficiently than other quality- and 
frequency-based strategies (42).
Determination of the V–D–J gene segments from which the 
CDR3s are rearranged, as well as identification of point mutations, 
is often achieved using the ImMunoGeneTics database (http://
www.imgt.org) (43), despite the controversies about its validity 
(44–46). New V–D–J gene annotation tools based on various 
algorithms are reported, such as IgBLAST (47), iHMMune-align 
(48), and Decombinator (49, 50) (Table  2). In addition, many 
integrated bioinformatic tools (MiTCR, LymAnalyzer, Change-O, 
etc.) for data processing are developed recently (51–62) (Table 2), 
which provides various statistical approaches for diversity esti-
mation, repertoire comparison, clustering analysis, and somatic 
hypermutation analysis (Table 3). Despite these tools, standard-
ized bioinformatic analysis and visualization strategy is lacking, 
which remains the main obstacle for comparison of researches 
from different investigators.
PROGReSS iN iNFeCTiON-ReLATeD 
iMMUNe RePeRTOiRe
High-throughput sequencing techniques have revolutionized 
the study of the immune repertoire. Utilizing HTS, many impor-
tant insights into mechanisms of immune response have been 
gained. It is also the cornerstone for potential clinical applica-
tions of repertoire analysis, including identification of diagnostic 
biomarkers, design of therapeutic antibodies, and development 
of new vaccines.
Assessing Dynamic Changes in the 
immune Repertoire after Antigen 
Stimulation
Estimating the diversity of a TCR/BCR repertoire is necessary 
for estimating the theoretical size of the repertoire and for track-
ing changes in clonal populations during the clinical course of 
infection. Several different methods may be used to describe 
the diversity of lymphocyte repertoires at different levels – VDJ 
recombination diversity (90), Simpson diversity index (91, 92), 
and some non-parametric methods. Decrease in the overall 
diversity of the immune repertoire have been observed after 
various antigen exposures, including HIV, influenza, and human 
herpes virus, which implies expansion of particular T/B cell 
clones (67, 88, 92, 93). Our group compared changes in the 
diversity of the TCR beta chain and BCR heavy chain after 
H7N9 virus infection. Interestingly, these results show that the 
diversity of the BCR heavy chain starts to increase 2 weeks after 
H7N9 infection, while the TCR beta chain repertoire continues 
to contract. In addition, a more diverse BCR repertoire and a 
less diverse TCR beta chain repertoire in convalescent phase 
correlate with improved prognoses, implying differences in the 
response process of humoral and cellular immunity.
The immune response to vaccination has been used as an ideal 
model for antibody repertoire research due to the convenience 
drawing blood samples at well-defined time points (94). Studies 
using vaccines, such as influenza and TT, have revealed dynamic 
changes in the size and diversity of antibody repertoires before 
and after antigen stimulation (41, 90, 95, 96). Comparison of 
post-vaccination responses suggests divergent repertoire prop-
erties among individuals, different age groups, and successive 
TABLe 2 | Annotation and integrated bioinformatic tools for Lymphocyte Repertoire Data Analysis.
Bioinformatic tools Models Key feature Limitation Cases of infection 
study
Reference
For vDJ gene assignment
IMGT/HighV-QUEST – Designed for NGS data; most commonly 
used
Online version; results sent to 
user after 1–2 weeks
MERS-CoV (63), 
influenza (64)
(65)
iHMMune-Align Hidden Markov 
model (HMM)
Most probable gene segment; accurate  
IGHD gene identification
Nucleotide insertions or deletions 
at the gene junctions but not 
within germline genes
Influenza vaccine (66); 
EBV, CMV (67)
(48)
SoDA2 Hidden Markov 
model (HMM)
Probability model; ≥1 probable 
rearrangement candidates
– HIV (68) (50)
IgBlast BLAST algorithm Open source; gene databases search  
simultaneously
Relatively low throughput 
(<1000 per batch)
Dengue virus (69); 
HIV (70)
(47)
Decombinator Aho–Corasick 
algorithm
Increased speed Better matches between query 
sequence and target sequence 
needed; only for TCR
M. tuberculosis (71) 
HIV (72)
(49)
integrated toolkits
O-Change Integrated Functions unique to BCR analysis (somatic 
hypermutation analysis, quantifying selection 
pressure, and calculating sequence chemical 
properties)
– West Nile Virus (73) (54)
LymAnalyzer Integrated Accurate and complete assignment; 
polymorphism and SHM analysis
– – (56)
tcR Integrated Based on R; diversity calculation; repertoire 
comparison; visualization
For output of MiTCR – (57)
iMonitor Integrated Re-alignment to improve accuracy; 
visualization; PCR and sequencing errors 
correction
No polymorphism and SHM 
analysis
– (59)
MiTCR Integrated Accurate and higher speed; PCR and 
sequencing errors correction; sequence 
quality filter; low quality sequencing data 
rescue
Strongly related to sequencing 
quality; only for TCR
CMV (74) (58)
ImmunExplorer 
(IMEX)
Integrated Simple statistical analysis and visualization; 
repertoire comparison
For IMGT/HighV-QUEST outputs – (55)
VDJtools Integrated Diversity assessment, clustering analysis, 
CDR3 region analysis, and data visualization; 
simple and user-friendly
Only for TCR; compatible 
annotation tools needed
– (61)
sciReptor Integrated Single-cell sequencing data and HTS 
data; supports flow cytometry index data; 
clustering and SHM analysis
– – (60)
Others
Tool for Ig genotype 
elucidation via Rep-
Seq (TIgGER)
Novel V alleles identification; personalized 
germline database construction
Complementary tools for IMGT; 
only for novel alleles not distantly 
related; only for TCR
(75)
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immunization of the same individual with different influenza 
vaccines (TIV and LAIV) (66, 90, 95). The maximum clonal 
response has been found to occur 7 days after vaccination, but 
the magnitude of response varies between individuals despite 
an identical immune challenge, which may be influenced by 
previous exposure, age, and other concurrent immune responses. 
In addition, study of B cell memory can be achieved by repeated 
sequencing of samples taken from the same individual in sepa-
rate immune responses to an antigen. Vollmers and colleagues 
identified a group of B-cell clones as a recall response to two 
substantially different vaccine compositions, implying the pos-
sibility of identifying cross-specific antibody using repertoire 
analysis (41).
Immune responses recorded by sequencing data have also been 
useful in testing the role of adjuvants in eliciting broad-spectrum 
antibodies. Wiley and co-workers tested the immune response 
of mice immunized with malaria vaccine by analyzing IgG rep-
ertoires. They found that TLR agonist used as adjuvant increases 
the diversity of IgG variable region, which is related to improved 
ability of the antibodies to recognize a broad spectrum of epitopes 
(97). These studies exemplify a new level of details assessing vac-
cine response and pioneered HTS implications in vaccine design.
Signatures of TCR/BCR Sequences for the 
Diagnosis of infectious Diseases
In infected patients, antigen-specific T/B cell repertoires form in 
response to antigen exposure in both circulation and peripheral 
tissues. Immune repertoire sequencing provides broad informa-
tion including crucial antigen-specific clones, which have the 
potential to halt the spread of pathogens (98). Diagnostic marker 
TABLe 3 | Statistical algorithms and models for Lymphocyte Repertoire 
Data Analysis.
Statistical methods Functions Reference
Maximum entropy models Statistical properties of the 
repertoire
(76)
Capture–recapture analysis Diversity assessment (77, 78)
Shannon index Diversity assessment (79)
Gini–Simpson index Diversity assessment (79, 80)
Chao1 algorithm Richness (maximum number 
of clones)
(81)
Abundance-based coverage 
estimator
Richness (maximum number 
of clones)
(82)
Chao2 Lower bound of species  
richness
(83) (84)
Wu–Kabat index
Poisson abundance model Diversity and clone distribution 
estimation
(85, 86)
Morisita–Horn similarity index Repertoire similarity comparison (87)
Clonality score Convergence-level estimation (67, 84, 88)
Hidden Markov model V and J assignment (probability 
based)
(48, 50)
Aho–Corasick algorithm V and J assignment (49)
Fast-tag-searching algorithm V and J assignment (Hamming 
distance based)
(56)
Single nucleotide polymorphism 
(SNP) calling algorithm
Identify novel VDJ gene alleles (89)
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discovery using sequencing data relies on these antigen-specific 
clones with stereotyped features in the post-infection repertoires. 
These features are assessed at different levels such as gene rear-
rangement, identical or similar CDR3 sequence overlap, and 
certain CDR3s length.
After influenza H1N1 vaccination, the dominant clonotype 
of Ig heavy chains has the same V–J gene rearrangement, CDR3 
length, and somatic mutation position in CDR1 and CDR3 with 
previously reported influenza antibodies (66). However, in this 
study, the convergent dominant sequence is only found in one 
individual. Further researches in a broader population including 
non-dominant sequences are needed. A more successful example 
is reported in Ig repertoires related to dengue virus infection. 
Using cross validation and other approaches, stereotyped CDR3 
sequences or CDR3 lengths that have high prevalence in the 
acute dengue samples are found to be specific to acute dengue 
infection, which are absent or of low prevalence in healthy and 
post-convalescent population (88).
Identification of pathogen-specific sequences also helps in 
differential diagnosis between infectious and non-infectious dis-
eases. According to Dziubianau et al., comparing PBMCs-derived 
T cell clonotypes specific to a given virus with T cells from dif-
ferent origins (allograft-derived and urine-derived lymphocytes) 
provides a new methodology for differential diagnosis of two 
post-transplant complications – BKV-associated nephropathy 
and acute cellular rejection, which shows a glimpse of applica-
tions of T cell sequencing in diagnosis (99). In addition, a recent 
study searched sequencing data for CDR3 amino acid motifs that 
have been reported to be specific for a particular pathogen and 
succeeded in identifying CDR3 sequences identical or similar to 
these motifs in post-vaccination volunteers (100). According to 
these results, interestingly, it is low frequency sequences that pos-
sess the probability of becoming promising biomarkers instead of 
the dominant ones.
However, immune responses show dramatic differences in 
CDR3 sequences responding to same pathogens across individu-
als and age groups. This intrinsic divergence between individuals 
is the major obstacle in finding “public” sequences as optimal 
biomarkers. Nevertheless, we hold a promise for the application 
of HTS data in differential diagnosis because it provides a large 
number of candidate sequences for biomarker investigation. 
Instead of using single biomarkers such as PSA or AFP in diag-
nosis, a combination panel of selected sequences may establish a 
pathogen-specific sequence library for diagnosis, which holds the 
potential of unprecedented sensitivity and specificity.
identification of Antigen-Specific 
Antibodies and T Cells Based on High-
Throughput Sequencing Data
Recombinant monoclonal antibodies have great potential in the 
treatment of specific infections. In recent years, several strategies, 
including phage display libraries, single B cell expression, and 
B cell immortalization, have been used to discover antibodies 
against specific antigens (101). HTS of the antibody repertoire, 
combined with subsequent bioinformatic tools or traditional 
screening tools, has facilitated the identification of antigen-
specific sequences (102–105).
The methodology predicting antigen specificity completely 
from analysis of BCR sequences has not been possible yet, 
albeit it has considerable potential in immune repertoire stud-
ies. Nevertheless, there have been many efforts made in mining 
the HTS data for functional antibodies (106). A relatively direct 
method for identifying such sequences is based on the similar-
ity of amino acid sequence to previously reported antibodies. 
Researchers have successfully found sequences of high identity 
with the broadly neutralizing antibodies and strain-specific 
antibodies from established antibody repertoires of patients with 
influenza infection or vaccination (66). Some of these sequences 
have proven to have neutralizing activity, validating the potential 
of deep sequencing-based antibody identification. Success of this 
work also suggests the possibility of monoclonal antibody synthe-
sis without cell cloning for treatment (66). Furthermore, another 
method using the frequency rank of heavy chain and light chain 
sequences to predict the function of antibody sequences has been 
reported successful in mouse models (107).
Exciting work by Kwong and coworkers demonstrates the 
feasibility of identifying neutralizing active clones through 
bioinformatic analysis from HIV patients (108, 109). They 
established several steps for interrogating variants of known 
neutralizing antibody classes from HIV-infected patients, with 
or without previous knowledge if the patient had antibodies 
belonging to this family. First, the heavy or light chain sequences, 
derived from the germline IGHV or IGLV gene same as template 
antibody, are isolated from a new donor. Then, these sequences 
were compared with the germline gene for “divergence” and the 
template antibody sequence for “identity,” generating a contour 
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plot called “divergence/identity plot.” The sequences segregate 
into clusters in the plot, from which the high divergence and 
high identity sequences were selected as candidates for neutral-
izing antibodies. This process is called “Grid-based strategy.” 
Then, the germline sequence, candidate sequences, and template 
antibody sequences of the same class are merged to build a phy-
logenetic tree rooted by the template sequence, which is called 
“cross-donor analysis.” The heavy chain sequences from new 
donor clustered in the subtree of the template sequences are then 
expressed with template light chain to generate antibodies. Most 
of these sequences have neutralizing activity to HIV-1. The out-
standing efficiency of this method was also demonstrated when 
compared to sequence-based strategy and prevalence-based 
strategy (108, 109). Lu et  al. also validated this phylogenetic 
method in identifying functional anti-Staphylococcus aureus 
antibodies (110). These strategies start from previously reported 
antibody sequences. However, such antibody sequences are not 
always available, especially during poorly characterized viral 
infections such as H7N9.
Pairing the heavy and light chains as an integrated antibody 
has been another challenge for HTS-based immune repertoire 
analysis. In most cases, researchers only focus on the heavy 
chain, which causes a critical loss of antibody integrity and 
leads to problems in following synthesis of artificial monoclonal 
antibody. Two strategies have been reported to correctly pair 
the heavy chain and light chain sequences based on the fre-
quency or evolution models. Reddy and colleagues (107) have 
pioneered pairing based on the frequency ranks, using plasma 
cells isolated from bone marrow of immunized mice and match-
ing the two chains of similar rank order. Monoclonal antibodies 
expressed in this way did show antigen specificity. Due to the 
linkage of heavy chain and light chain as an integrated protein, 
their evolution undergoes the same enzymatic mutation pro-
cess, and they evolve together to bind the same antigen with 
high affinity. Based on this theoretical foundation, phylogenic 
analysis has been used as another method to compare the evo-
lutionary topography of the heavy chain and light chain after 
bioinformatic identification of transcripts related to a known 
HIV neutralizing antibody (109, 111). Reconstituted novel 
antibodies consist of phylogenetically matched chains showing 
similar neutralizing function but less auto-reactivity compared 
to the mismatched ones.
Several groups have recently achieved advances in the technol-
ogy of paired sequencing of antibodies. Single-cell PCR has been 
utilized to create a two-dimensional bar-coded primer matrix to 
link two chains of the BCR (112). Using this technique, Busse and 
coworkers analyzed paired sequences of over 46,000 B cells in one 
experiment and accomplished subsequent antibody gene cloning 
and expression. At the same time, Turchaninova and coworkers 
performed pioneering research in emulsion-based technology 
for sequencing antibody repertoires of paired chains (113). They 
used water-in-oil emulsions for cell-based overlap expansion 
RT-PCR, although its yield was relatively low yield. Another 
high-throughput paired sequencing method by DeKosky et  al. 
used micro well plates to isolate B cells and magnetic beads to 
capture mRNAs (114). Very recently, DeKosky’s group combined 
and improved these previous techniques, and developed a cost-
effective and efficient methodology to establish a more precisely 
paired repertoire (115).
Predicting T cell specificity based on TCR heterodimer 
sequence is more difficult than antibodies because of the highly 
variable nature of each of the components of the TCR–peptide–
MHC complex (116). Due to the challenges posed by the highly 
variable CDR3 loop of the TCR and the complexity of predicting 
protein–protein interactions (117, 118), experimental functional 
tests for mining antigen-specific T cells might be a more fruitful 
approach (119).
implementation of immune Repertoire 
Analysis in vaccine Development
Recent advances in HTS-based antibody sequencing may provide 
the biggest benefit for the field of vaccine development. Over the 
years, efforts to elicit protective immune responses to HIV by 
immunization have not been successful. During acute viral infec-
tions, high-affinity neutralizing antibodies develop in just weeks. 
However, generating effective broadly neutralizing antibodies 
during chronic infections, such as HIV, takes significantly longer 
time. Furthermore, the neutralizing power of these antibodies is 
often variable due to impairment of the host immune function, 
unusual features of Env, and co-evolution of the virus in response 
to the host antibody response (120, 121).
Deep sequencing analysis has identified rare variants of known 
HIV-neutralizing antibodies and has elucidated the ontogeny of 
these neutralizing antibodies (108, 109, 111, 122). These findings 
have cast a light on antibody guided vaccine development. In 
following studies, the HTS-based phylogenetic strategy greatly 
facilitated study in co-evolution of neutralizing antibodies and 
virus mutants (123). Combined with long-term follow-up studies, 
these results illustrate how mutations in some sites allow the virus 
to escape some neutralizing antibodies, and how the virus, with 
the help of secondary neutralizing antibodies, becomes sensitive 
to the neutralizing antibody (98, 124, 125). These studies suggest 
a promising pathway to elicit broadly neutralizing antibodies by 
sequential immunization with selected immunogens (123, 126). 
Furthermore, structure studies of the neutralizing antibody fam-
ily provide candidates for future vaccine designs (127).
CONCLUSiON
High-throughput sequencing has been a breakthrough technol-
ogy for the study of the immune repertoire and has already had 
a profound effect on our knowledge of the immune systems 
physiology during health and disease. In particular, HTS has 
transformed our understanding of immune repertoire formation 
during infection, malignancy, and autoimmunity. Advances in 
this filed of research will rely on progress of similar laboratory 
techniques. Collection of more precise sequencing data can be 
anticipated with consistent improvement of sequencing tech-
niques and error correction strategies. An increasing number 
of researchers have shown interest in this area in recent years, 
and this has provided vast quantities of data that could provide 
answers to important existing questions. These data repositories 
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should be effectively utilized. Establishing a public database and 
collecting deep sequencing data for collective collaboration will 
facilitate information exchange and the investigation of the varie-
ties of repertoires across gender, age, race, and healthy state. In 
addition, development of standardized bioinformatic tools will 
be indispensable for harnessing HTS output.
Although the expected potential of immune repertoire stud-
ies in clinical use is enormous, more work remains to be done 
to incorporate the observed dynamic changes and sequence 
signatures with clinical features and outcomes. Questions remain 
about how the severity of certain infections is related to alterations 
of the immune repertoire response and various manifestations of 
CDR3 sequences, and how to predict abundance of protective 
immunoglobulins or T cell from a given sequence library. In 
terms of therapeutic discoveries, identification and production 
of functional antibodies and T cells will promote the develop-
ment of passive immune therapies and vaccines. Traditional and 
recently reported large-scale screening strategies may contribute 
greatly to this process. Advances in HTS of the immune reper-
toire during health and disease will provide comprehensive views 
of the adaptive immune response in very near future and will 
open the door to more rationale immunotherapy for infection.
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